Multiway analysis methods applied to the fluorescence excitation-emission dataset for the simultaneous quantification of valsartan and amlodipine in tablets


Dinc E., Ertekin Z. C. , Buker E.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, vol.184, pp.255-261, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 184
  • Publication Date: 2017
  • Doi Number: 10.1016/j.saa.2017.04.081
  • Title of Journal : SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
  • Page Numbers: pp.255-261
  • Keywords: Excitation-emission matrix, Three-way analysis, Quantification, Valsartan, Amlodipine besylate, PRINCIPAL COMPONENT ANALYSIS, PARALLEL FACTOR-ANALYSIS, 3-MODE FACTOR-ANALYSIS, HUMAN PLASMA, SPECTROFLUOROMETRIC DETERMINATION, SPECTROPHOTOMETRIC DETERMINATION, 2ND-ORDER CALIBRATION, MULTILINEAR PLS, SENSITIVE HPLC, URINE SAMPLES

Abstract

In this study, excitation-emission matrix datasets, which have strong overlapping bands, were processed by using four different chemometric calibration algorithms consisting of parallel factor analysis, Tucker3, three-way partial least squares and unfolded partial least squares for the simultaneous quantitative estimation of valsartan and amlodipine besylate in tablets. In analyses, preliminary separation step was not used before the application of parallel factor analysis Tucker3, three-way partial least squares and unfolded partial least squares approaches for the analysis of the related drug substances in samples. Three-way excitation-emission matrix data array was obtained by concatenating excitation-emission matrices of the calibration set, validation set, and commercial tablet samples. The excitation-emission matrix data array was used to get parallel factor analysis, Tucker3, threeway partial least squares and unfolded partial least squares calibrations and to predict the amounts of valsartan and amlodipine besylate in samples. For all the methods, calibration and prediction of valsartan and amlodipine besylate were performed in the working concentration ranges of 0.25-4.50 mu g/mL. The validity and the performance of all the proposed methods were checked by using the validation parameters. From the analysis results, it was concluded that the described two-way and three-way algorithmic methods were very useful for the simultaneous quantitative resolution and routine analysis of the related drug substances in marketed samples. (C) 2017 Elsevier B.V. All rights reserved.